About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The search for quality and innovation has always been an inherent part of the activity of the Stroke Research Group and represents the common thread that leads us to excellence and continuous improvement.
In recent years, the Stroke Research Group has established itself as a leader in the management, recruitment and international coordination of multicenter clinical trials, as well as in the development of patents for new thrombectomy devices and the creation of new technological solutions and digital platforms to improve the diagnosis, treatment and follow-up of stroke patients. Robust strategic alliances have also been consolidated with public and private entities that ensure the viability and scalability of the research projects initiated in our group.
The Stroke Research Group is made up of a transversal and multidisciplinary team that shares a common idea: to contribute from its area of knowledge to the care and management of stroke through the effective transfer of knowledge and the complementarity of the processes of clinical research.
Responsible: Dr. Marta Rubiera
IP: -
Responsible: Dr. David Rodríguez Luna
Responsible: Dr. Jorge Pagola
IP: Laura Abraira Del Fresno Collaborators: Anna Penalba Morenilla, Manuel Toledo Argany, Olalla Pancorbo Rosal, Estevo Santamarina Pérez, Manuel Quintana Luque Funding agency: Instituto de Salud Carlos III Funding: 102500 Reference: PI24/01233 Duration: 01/01/2025 - 31/12/2027
IP: Jorge Pagola Pérez Blanca Collaborators: José Alvarez Sabin, Noelia Rodríguez Villatoro, Jaume Francisco Pascual, Hug Cuellar Calabria, Ruben Fernández Galera, Federica Rizzo, Claudia Meza Burgos Funding agency: Instituto de Salud Carlos III Funding: 61250 Reference: PI24/00333 Duration: 01/01/2025 - 31/12/2027
IP: Carlos Molina Cateriano Collaborators: Olalla Pancorbo Rosal, Carole Conforti Funding agency: EUROPEAN COMMISSION Funding: 1131945 Reference: EASTSTROKE_HE-HLTH-2024 Duration: 01/12/2024 - 30/11/2030
IP: Marc Ribó Jacobi Collaborators: - Funding agency: Fundació "La Caixa" Funding: 395016 Reference: HR24-00927 Duration: 01/11/2024 - 31/10/2027
PhD student: Marc Rodrigo Gisbert Director/s: Marc Ribó Jacobi, Manuel Requena Ruiz University: Universitat Autònoma de Barcelona Year: 2025
PhD student: Olalla Pancorbo Rosal Director/s: David Rodriguez Luna University: Universitat Autònoma de Barcelona Year: 2024
PhD student: Pere Canals Canals, Pere Canals Canals Director/s: Marc Ribó Jacobi University: Universitat Autònoma de Barcelona Year: 2024
PhD student: Jiahui Li , Jiahui Li Director/s: Marc Ribó Jacobi University: Universitat Autònoma de Barcelona Year: 2022
PhD student: María del Carmen Parra Fariñas Director/s: Marc Ribó Jacobi University: Universitat Autònoma de Barcelona Year: 2022
PhD student: Marta Olive Gadea, Marta Olive Gadea Director/s: José Alvarez Sabin, Marta Aurora Rubiera Del Fueyo University: Year: 2022
PhD student: Jesus Maria Juega Mariño Director/s: Carlos Molina Cateriano, Jorge Pagola Pérez Blanca University: Year: 2021
PhD student: Manuel Requena Ruiz, Manuel Requena Ruiz, Manuel Requena Ruiz Director/s: Carlos Molina Cateriano University: Universidad Autònoma de Barcelona Year: 2020
PhD student: Sandra Boned Riera Director/s: Marc Ribó Jacobi, Carlos Molina Cateriano University: Universidad Autònoma de Barcelona Year: 2019
PhD student: Noelia Rodríguez Villatoro, Noelia Rodríguez Villatoro, Noelia Rodríguez Villatoro Director/s: José Alvarez Sabin, David Rodriguez Luna, Carlos Molina Cateriano University: Universidad Autònoma de Barcelona Year: 2019
PhD student: Sandra Boned Riera Director/s: José Alvarez Sabin, Marc Ribó Jacobi, Carlos Molina Cateriano University: Universidad Autònoma de Barcelona Year: 2019
PhD student: Mª Ángeles Muchada López Director/s: José Alvarez Sabin, Marta Aurora Rubiera Del Fueyo, Carlos Molina Cateriano University: Universidad Autònoma de Barcelona Year: 2014
PhD student: Estela Sanjuan Menendez, Estela Sanjuan Menendez Director/s: University: Universidad Autònoma de Barcelona Year: 2014
PhD student: David Rodriguez Luna Director/s: José Alvarez Sabin, Carlos Molina Cateriano University: Universidad Autònoma de Barcelona Year: 2012
PhD student: Jorge Pagola Pérez Blanca Director/s: José Alvarez Sabin, Marc Ribó Jacobi, Carlos Molina Cateriano University: Universidad Autònoma de Barcelona Year: 2010
PhD student: Marta Aurora Rubiera Del Fueyo Director/s: University: Universidad Autònoma de Barcelona Year: 2006
PhD student: Marc Ribó Jacobi Director/s: University: Universidad Autònoma de Barcelona Year: 2004
Funding has been obtained for 43 projects under the calls for Health R&D&I Projects, Health Technology Development, and Independent Clinical Research
The study analyzes a new therapeutic strategy in high-risk patients that could influence future international clinical guidelines
The Stroke Research and the Neurovascular Diseases groups lead innovative research projects in both clinical and translational areas.
